title: Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites?
authors.forename: Sandip
authors.initials: S
authors.lastname: Basu
authors.forename: Abass
authors.initials: A
authors.lastname: Alavi
mesh_terms: D002277:Carcinoma / Q000000981:diagnostic imaging* / Q000473:pathology; D002986:Clinical Trials as Topic / Q000592:standards*; D004938:Esophageal Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D019788:Fluorodeoxyglucose F18; D017408:Guidelines as Topic; D006801:Humans; D049268:Positron-Emission Tomography / Q000592:standards*; D011785:Quality Assurance, Health Care / Q000379:methods / Q000592:standards*; D011859:Radiography; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18